| J3245 | Injection, tildrakizumab, 1 mg | 6,600 | $110 | $726K |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 41,100 | $20 | $698.7K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,870 | $30 | $100.6K |
| J0485 | Injection, belatacept, 1 mg | 30,830 | $1 | $92.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 350 | $80 | $28.2K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 270 | $40 | $12K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 90 | $40 | $3.4K |
| 99349 | The provider sees an established patient for a home or residence visit involving evaluation and management (E/M). The visit involves moderate medical decision making or the provider spends at least… | 20 | $80 | $1.4K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 80 | $20 | $1.3K |
| 99348 | The provider sees an established patient for a home or residence visit involving evaluation and management (E/M). The visit involves low medical decision making or the provider spends at least 30… | 20 | $50 | $830 |